Nelson DR - Search Results

1

Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders.

Nelson DR, Lauwers GY, Lau JY, Davis GL. Nelson DR, et al. Gastroenterology. 2000 Apr;118(4):655-60. doi: 10.1016/s0016-5085(00)70134-x. Gastroenterology. 2000. PMID: 10734016 Clinical Trial.

2

Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3.

Nelson DR, Benhamou Y, Chuang WL, Lawitz EJ, Rodriguez-Torres M, Flisiak R, Rasenack JW, Kryczka W, Lee CM, Bain VG, Pianko S, Patel K, Cronin PW, Pulkstenis E, Subramanian GM, McHutchison JG; ACHIEVE-2/3 Study Team. Nelson DR, et al. Gastroenterology. 2010 Oct;139(4):1267-76. doi: 10.1053/j.gastro.2010.06.062. Epub 2010 Jul 1. Gastroenterology. 2010. PMID: 20600017 Free PMC article. Clinical Trial.

3

alpha-Glutathione S-transferase as a marker of hepatocellular damage in chronic hepatitis C virus infection.

Nelson DR, Lim HL, Oliver D, Qian KP, Davis GL, Lau JY. Nelson DR, et al. Am J Clin Pathol. 1995 Aug;104(2):193-8. doi: 10.1093/ajcp/104.2.193. Am J Clin Pathol. 1995. PMID: 7639195

4

Variations of hepatitis C virus NS5B sequence (nucleotides 8261-8566) do not correlate with response to interferon-alpha therapy.

Nelson DR, Gray AH, Kolberg JA, Joh J, Urdea MS, Mizokami M, Davis GL, Lau JY. Nelson DR, et al. J Viral Hepat. 1995;2(6):285-92. doi: 10.1111/j.1365-2893.1995.tb00043.x. J Viral Hepat. 1995. PMID: 8732174 Clinical Trial.

5

The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.

Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, Lau JY. Nelson DR, et al. J Immunol. 1997 Feb 1;158(3):1473-81. J Immunol. 1997. PMID: 9013994

6

Transforming growth factor-beta 1 in chronic hepatitis C.

Nelson DR, Gonzalez-Peralta RP, Qian K, Xu Y, Marousis CG, Davis GL, Lau JY. Nelson DR, et al. J Viral Hepat. 1997 Jan;4(1):29-35. doi: 10.1046/j.1365-2893.1997.00124.x. J Viral Hepat. 1997. PMID: 9031062

7

Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection.

Reiser M, Marousis CG, Nelson DR, Lauer G, González-Peralta RP, Davis GL, Lau JY. Reiser M, et al. Among authors: nelson dr. J Hepatol. 1997 Mar;26(3):471-8. doi: 10.1016/s0168-8278(97)80409-6. J Hepatol. 1997. PMID: 9075651

8

Treatment of chronic hepatitis C.

Nelson DR, Davis GL. Nelson DR, et al. Compr Ther. 1997 Apr;23(4):269-76. Compr Ther. 1997. PMID: 9167919 Review. No abstract available.

9

Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection.

Nelson DR, Lim HL, Marousis CG, Fang JW, Davis GL, Shen L, Urdea MS, Kolberg JA, Lau JY. Nelson DR, et al. Dig Dis Sci. 1997 Dec;42(12):2487-94. doi: 10.1023/a:1018804426724. Dig Dis Sci. 1997. PMID: 9440625

10

Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.

Nelson DR, Marousis CG, Ohno T, Davis GL, Lau JY. Nelson DR, et al. Hepatology. 1998 Jul;28(1):225-30. doi: 10.1002/hep.510280129. Hepatology. 1998. PMID: 9657116

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

930 results

Search Page